Hype or Helpful: Does Patient Involvement Strengthen Lung Cancer Research? Scientists Weigh In.
Read time: 1 minute. Patient research advocates bring their personal experience into the research process, helping studies ask questions that matter to people affected by lung
Recent
-
What Is the Impact of Low-Grade Side Effects (Such As Diarrhea) on Patients’ Quality-of-Life?
Read time: 1 minute. When people hear the phrase “low grade” in cancer treatment, it can sound reassuring. But for patients, a side effect that is not life-threatening can still -
Testing an Innovative Approach To Promote Lung Cancer Screening in a Large Hospital System Serving Minority Populations
Read time: 1 minute. Getting screened for lung cancer can save lives, but many people who qualify for screening never receive it. A LUNGevity-supported study presented at the 2026 -
Conversations that Count: Improving Palliative Pain Management in Response to Improving Cancer Prognoses
The LUNGevity Conversations that Count speaker series offers an opportunity to stay informed, engage in critical discussions, and learn from leading experts advancing lung cancer
Survivor Spotlight
-
Podcast: Managing the Emotional Rollercoaster of Lung Cancer
Living with lung cancer can take more than just a physical toll—it comes with a myriad of feelings, like anxiety, fear, and grief. In this episode, non-small cell lung cancer -
Camila Bermúdez García: Turning Experience into Advocacy
Read time: 5 minutes. Before lung cancer entered her life, 24-year-old Camila Bermudez Garcia was focused on building her future. Growing up as the oldest of three in Ponce, Puerto -
Podcast: What are Biomarkers and Why Should You Get Tested?
What are biomarkers, why do they matter, and what should every person living with lung cancer know about getting tested? Dr. Ross Camidge, a world-renowned thoracic oncologist and